Celularity Stock Cash Per Share

CELUW Stock

USD 0.02 0 5.29%

Celularity fundamentals help investors to digest information that contributes to Celularity's financial success or failures. It also enables traders to predict the movement of Celularity Stock. The fundamental analysis module provides a way to measure Celularity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celularity stock.

		Last Reported	Projected for Next Year
	Cash Per Share	0.01	0.01

Cash Per Share is likely to drop to 0.01 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Celularity Company Cash Per Share Analysis

Celularity's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Cash Per Share

Total Cash

Average Shares

More About Cash Per Share | All Equity Analysis

Current Celularity Cash Per Share

0.27 X

Most of Celularity's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celularity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Celularity Cash Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Celularity is extremely important. It helps to project a fair market value of Celularity Stock properly, considering its historical fundamentals such as Cash Per Share. Since Celularity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Celularity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Celularity's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Common Stock	Net Tangible Assets	Accounts Payable	Net Receivables	Good Will	Capital Surpluse	Intangible Assets	Current Deferred Revenue	Short Term Investments	Deferred Long Term Liab	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Debt	Short Long Term Debt
Total Assets		-0.08	0.22	-0.68	0.74	0.83	0.27	-0.7	0.41	0.56	-0.09	0.79	-0.58	-0.55	-0.04	-0.04	0.58	0.49	-0.32	0.28	0.04
Total Stockholder Equity	-0.08		0.64	0.08	-0.73	-0.53	0.42	0.13	0.07	-0.11	-0.08	-0.17	0.08	-0.32	-0.08	-0.08	0.34	0.31	-0.26	0.24	0.07
Net Debt	0.22	0.64		-0.5	-0.28	0.02	0.25	-0.48	0.48	0.56	-0.63	0.35	-0.55	-0.67	-0.58	-0.58	0.7	0.73	-0.84	0.86	0.55
Retained Earnings	-0.68	0.08	-0.5		-0.52	-0.78	0.19	1.0	-0.87	-0.94	0.72	-0.94	0.98	0.9	0.64	0.64	-0.89	-0.9	0.83	-0.79	-0.6
Total Liab	0.74	-0.73	-0.28	-0.52		0.93	-0.09	-0.57	0.24	0.46	-0.01	0.66	-0.45	-0.16	0.02	0.02	0.17	0.13	-0.05	0.03	-0.02
Total Current Assets	0.83	-0.53	0.02	-0.78	0.93		-0.15	-0.81	0.47	0.68	-0.26	0.85	-0.72	-0.49	-0.24	-0.24	0.5	0.45	-0.38	0.35	0.24
Common Stock	0.27	0.42	0.25	0.19	-0.09	-0.15		0.19	-0.15	-0.17	0.11	-0.18	0.18	0.16	0.1	0.1	-0.16	-0.16	0.14	-0.13	-0.09
Net Tangible Assets	-0.7	0.13	-0.48	1.0	-0.57	-0.81	0.19		-0.85	-0.95	0.71	-0.95	0.98	0.87	0.63	0.63	-0.86	-0.87	0.81	-0.78	-0.59
Accounts Payable	0.41	0.07	0.48	-0.87	0.24	0.47	-0.15	-0.85		0.89	-0.81	0.81	-0.88	-0.86	-0.63	-0.63	0.79	0.89	-0.78	0.72	0.54
Net Receivables	0.56	-0.11	0.56	-0.94	0.46	0.68	-0.17	-0.95	0.89		-0.78	0.91	-0.95	-0.83	-0.62	-0.62	0.8	0.88	-0.87	0.84	0.55
Good Will	-0.09	-0.08	-0.63	0.72	-0.01	-0.26	0.11	0.71	-0.81	-0.78		-0.5	0.83	0.68	0.94	0.94	-0.62	-0.74	0.87	-0.86	-0.89
Capital Surpluse	0.79	-0.17	0.35	-0.94	0.66	0.85	-0.18	-0.95	0.81	0.91	-0.5		-0.88	-0.82	-0.36	-0.36	0.81	0.82	-0.68	0.63	0.3
Intangible Assets	-0.58	0.08	-0.55	0.98	-0.45	-0.72	0.18	0.98	-0.88	-0.95	0.83	-0.88		0.87	0.75	0.75	-0.85	-0.89	0.88	-0.85	-0.71
Current Deferred Revenue	-0.55	-0.32	-0.67	0.9	-0.16	-0.49	0.16	0.87	-0.86	-0.83	0.68	-0.82	0.87		0.58	0.58	-0.99	-0.98	0.86	-0.81	-0.54
Short Term Investments	-0.04	-0.08	-0.58	0.64	0.02	-0.24	0.1	0.63	-0.63	-0.62	0.94	-0.36	0.75	0.58		1.0	-0.56	-0.61	0.79	-0.8	-0.99
Deferred Long Term Liab	-0.04	-0.08	-0.58	0.64	0.02	-0.24	0.1	0.63	-0.63	-0.62	0.94	-0.36	0.75	0.58	1.0		-0.56	-0.61	0.79	-0.8	-0.99
Net Invested Capital	0.58	0.34	0.7	-0.89	0.17	0.5	-0.16	-0.86	0.79	0.8	-0.62	0.81	-0.85	-0.99	-0.56	-0.56		0.97	-0.87	0.83	0.52
Capital Stock	0.49	0.31	0.73	-0.9	0.13	0.45	-0.16	-0.87	0.89	0.88	-0.74	0.82	-0.89	-0.98	-0.61	-0.61	0.97		-0.92	0.88	0.55
Net Working Capital	-0.32	-0.26	-0.84	0.83	-0.05	-0.38	0.14	0.81	-0.78	-0.87	0.87	-0.68	0.88	0.86	0.79	0.79	-0.87	-0.92		-1.0	-0.74
Short Term Debt	0.28	0.24	0.86	-0.79	0.03	0.35	-0.13	-0.78	0.72	0.84	-0.86	0.63	-0.85	-0.81	-0.8	-0.8	0.83	0.88	-1.0		0.76
Short Long Term Debt	0.04	0.07	0.55	-0.6	-0.02	0.24	-0.09	-0.59	0.54	0.55	-0.89	0.3	-0.71	-0.54	-0.99	-0.99	0.52	0.55	-0.74	0.76

Click cells to compare fundamentals

Celularity Cash Per Share Historical Pattern

Today, most investors in Celularity Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Celularity's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Celularity cash per share as a starting point in their analysis.

Celularity Cash Per Share

Timeline

Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

Competition

Predict Celularity

Cash Per Share Over Time

Celularity Common Stock Shares Outstanding

Common Stock Shares Outstanding

11.82 Million

At this time, Celularity's Common Stock Shares Outstanding is fairly stable compared to the past year.

In accordance with the recently published financial statements, Celularity has a Cash Per Share of 0.27 times. This is 93.79% lower than that of the Biotechnology sector and 93.76% lower than that of the Health Care industry. The cash per share for all United States stocks is 94.61% higher than that of the company.

Celularity Cash Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Celularity's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Celularity could also be used in its relative valuation, which is a method of valuing Celularity by comparing valuation metrics of similar companies.

Celularity is currently under evaluation in cash per share category among its peers.

Celularity Fundamentals

	Return On Equity	-1.54
	Return On Asset	-0.15
	Profit Margin	(2.64) %
	Operating Margin	(0.84) %
	Number Of Shares Shorted	168.34 K
	Revenue	22.77 M
	EBITDA	(35.91 M)
	Net Income	(196.29 M)
	Cash And Equivalents	38 M
	Cash Per Share	0.27 X
	Total Debt	39.24 M
	Debt To Equity	0.18 %
	Current Ratio	2.29 X
	Book Value Per Share	1.27 X
	Cash Flow From Operations	(38.69 M)
	Earnings Per Share	(0.87) X
	Number Of Employees	120
	Beta	0.51
	Total Asset	143.89 M
	Retained Earnings	(841.79 M)
	Working Capital	(47.51 M)
	Net Asset	143.89 M

About Celularity Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Celularity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celularity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celularity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC